By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioo Scientific and Jungwoo F&B are partnering in an effort to improve methods of cancer diagnosis and treatment, the Austin, Texas-based company said on Monday.

As part of the collaboration Bioo will develop kits for use on Jungwoo's Image Oriented Navigation Laser Microdissection Device imaging platform. Bioo will also develop kits for global microRNA profiling and for protein extraction for peptide analysis of tumor samples using mass spectrometry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.